| 2.8 |
17.0 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.6 |
4.9 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.6 |
6.3 |
GO:2000768 |
positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.9 |
2.6 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.7 |
2.1 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.6 |
2.5 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.6 |
1.8 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 0.6 |
2.4 |
GO:0097168 |
condensed mesenchymal cell proliferation(GO:0072137) mesenchymal stem cell proliferation(GO:0097168) |
| 0.6 |
2.4 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) pulmonary myocardium development(GO:0003350) subthalamus development(GO:0021539) subthalamic nucleus development(GO:0021763) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
| 0.6 |
1.2 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.6 |
3.5 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.5 |
1.6 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.5 |
2.6 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.5 |
1.5 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.5 |
1.4 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.4 |
0.4 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.4 |
4.1 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.4 |
12.8 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.4 |
1.1 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.3 |
1.0 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.3 |
1.7 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.3 |
0.6 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.3 |
2.3 |
GO:0090195 |
chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
| 0.3 |
2.1 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.3 |
0.8 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.3 |
5.1 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.2 |
0.7 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.2 |
0.5 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.2 |
0.2 |
GO:0016114 |
terpenoid biosynthetic process(GO:0016114) |
| 0.2 |
0.9 |
GO:1904749 |
rRNA export from nucleus(GO:0006407) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 |
4.3 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.2 |
0.2 |
GO:0060298 |
positive regulation of sarcomere organization(GO:0060298) |
| 0.2 |
1.9 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.2 |
1.7 |
GO:0055064 |
carbon dioxide transport(GO:0015670) chloride ion homeostasis(GO:0055064) |
| 0.2 |
0.6 |
GO:0009193 |
pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
| 0.2 |
0.6 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.2 |
0.6 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.2 |
1.2 |
GO:0032346 |
positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 0.2 |
0.8 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.2 |
1.2 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 |
1.3 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.2 |
1.0 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.2 |
0.6 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.2 |
0.6 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 0.2 |
1.1 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.2 |
0.6 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.2 |
1.8 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.2 |
0.9 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.2 |
2.1 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.2 |
0.5 |
GO:0032632 |
interleukin-3 production(GO:0032632) |
| 0.2 |
0.5 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.2 |
0.8 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 |
2.4 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.2 |
0.5 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.2 |
0.5 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.1 |
0.7 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.1 |
0.7 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.1 |
0.7 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 |
0.7 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
0.4 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 |
0.4 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.1 |
1.1 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.1 |
0.3 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.1 |
0.5 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.1 |
0.5 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.4 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.1 |
0.5 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.1 |
0.3 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 |
1.6 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
0.2 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.1 |
0.5 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
1.0 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.1 |
4.6 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.1 |
0.8 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.1 |
0.6 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
| 0.1 |
0.3 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
1.3 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.6 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.1 |
3.5 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.1 |
1.8 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
2.6 |
GO:0071398 |
cellular response to fatty acid(GO:0071398) |
| 0.1 |
0.7 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.1 |
0.4 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.1 |
2.3 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.3 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
4.7 |
GO:0021884 |
forebrain neuron development(GO:0021884) |
| 0.1 |
0.5 |
GO:0061085 |
regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
0.4 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.1 |
0.4 |
GO:0070942 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) |
| 0.1 |
0.3 |
GO:0021892 |
cerebral cortex GABAergic interneuron differentiation(GO:0021892) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 0.1 |
1.1 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.1 |
0.8 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
1.0 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.1 |
0.3 |
GO:0045908 |
negative regulation of vasodilation(GO:0045908) |
| 0.1 |
0.3 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.1 |
2.2 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
1.9 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.1 |
0.7 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.8 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
2.2 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
0.7 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.2 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) regulation of vascular wound healing(GO:0061043) glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.1 |
0.4 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
0.2 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.1 |
0.2 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.2 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.4 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 |
0.4 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 |
2.6 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.1 |
1.8 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.1 |
0.4 |
GO:0071638 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.1 |
0.6 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.1 |
1.1 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.9 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.1 |
2.4 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.1 |
0.4 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
0.3 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.0 |
0.7 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
1.1 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
1.0 |
GO:0019432 |
triglyceride biosynthetic process(GO:0019432) |
| 0.0 |
0.4 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.2 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.0 |
0.7 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.2 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
| 0.0 |
0.2 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
| 0.0 |
0.4 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.2 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 |
0.7 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.7 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 |
0.2 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.3 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
1.2 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.0 |
0.2 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.0 |
1.8 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.1 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.0 |
0.4 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.0 |
0.3 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
1.2 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 |
1.9 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.0 |
1.2 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
1.2 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.0 |
0.2 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 |
0.2 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.0 |
0.1 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 |
0.1 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 |
0.2 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.0 |
0.2 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.0 |
0.0 |
GO:0046881 |
sperm ejaculation(GO:0042713) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.0 |
0.5 |
GO:0045787 |
positive regulation of cell cycle(GO:0045787) |
| 0.0 |
0.7 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.8 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.0 |
0.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.1 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.0 |
0.8 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.0 |
0.4 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.3 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.9 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.0 |
0.3 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 |
2.5 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
1.4 |
GO:0035914 |
skeletal muscle cell differentiation(GO:0035914) |
| 0.0 |
1.2 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
1.8 |
GO:0007286 |
spermatid development(GO:0007286) |
| 0.0 |
0.2 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.0 |
3.2 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
0.4 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.0 |
0.2 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.1 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.0 |
0.4 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.0 |
0.7 |
GO:0042632 |
cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.0 |
0.1 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.0 |
0.3 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.0 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.0 |
0.5 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.8 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.2 |
GO:0035337 |
fatty-acyl-CoA metabolic process(GO:0035337) |
| 0.0 |
0.2 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.3 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
0.2 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.6 |
GO:0060479 |
lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
| 0.0 |
0.3 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
0.5 |
GO:0006303 |
double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.0 |
0.7 |
GO:0007091 |
metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
| 0.0 |
0.2 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
0.1 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.0 |
0.4 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 |
0.2 |
GO:0001523 |
retinoid metabolic process(GO:0001523) |
| 0.0 |
0.6 |
GO:0006261 |
DNA-dependent DNA replication(GO:0006261) |
| 0.0 |
0.4 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.1 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.0 |
0.2 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
0.0 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 |
1.4 |
GO:0010466 |
negative regulation of peptidase activity(GO:0010466) |
| 0.0 |
0.2 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.0 |
0.2 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
0.5 |
GO:0006418 |
tRNA aminoacylation for protein translation(GO:0006418) |
